Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11439 | 915 | 47.0 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | IL 24 | Author keyword | 95 | 82% | 6% | 55 |
2 | MDA 7 | Author keyword | 87 | 83% | 5% | 49 |
3 | IL 22 | Author keyword | 62 | 44% | 12% | 107 |
4 | MDA 7 IL 24 | Author keyword | 59 | 81% | 4% | 35 |
5 | INTERLEUKIN 22 | Author keyword | 50 | 55% | 7% | 62 |
6 | INTERLEUKIN 19 | Author keyword | 41 | 87% | 2% | 20 |
7 | IL 20 | Author keyword | 38 | 76% | 3% | 26 |
8 | INTERLEUKIN 20 | Author keyword | 37 | 100% | 2% | 14 |
9 | IL 19 | Author keyword | 36 | 83% | 2% | 20 |
10 | INTERLEUKIN 24 | Author keyword | 22 | 57% | 3% | 26 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IL 24 | 95 | 82% | 6% | 55 | Search IL+24 | Search IL+24 |
2 | MDA 7 | 87 | 83% | 5% | 49 | Search MDA+7 | Search MDA+7 |
3 | IL 22 | 62 | 44% | 12% | 107 | Search IL+22 | Search IL+22 |
4 | MDA 7 IL 24 | 59 | 81% | 4% | 35 | Search MDA+7+IL+24 | Search MDA+7+IL+24 |
5 | INTERLEUKIN 22 | 50 | 55% | 7% | 62 | Search INTERLEUKIN+22 | Search INTERLEUKIN+22 |
6 | INTERLEUKIN 19 | 41 | 87% | 2% | 20 | Search INTERLEUKIN+19 | Search INTERLEUKIN+19 |
7 | IL 20 | 38 | 76% | 3% | 26 | Search IL+20 | Search IL+20 |
8 | INTERLEUKIN 20 | 37 | 100% | 2% | 14 | Search INTERLEUKIN+20 | Search INTERLEUKIN+20 |
9 | IL 19 | 36 | 83% | 2% | 20 | Search IL+19 | Search IL+19 |
10 | INTERLEUKIN 24 | 22 | 57% | 3% | 26 | Search INTERLEUKIN+24 | Search INTERLEUKIN+24 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IL TIF | 216 | 98% | 6% | 54 |
2 | DIFFERENTIATION ASSOCIATED GENE 7 | 193 | 84% | 12% | 107 |
3 | DIFFERENTIATION ASSOCIATED GENE | 170 | 80% | 11% | 105 |
4 | MELANOMA DIFFERENTIATION | 157 | 82% | 10% | 93 |
5 | HUMAN MELANOMA DIFFERENTIATION | 136 | 94% | 5% | 48 |
6 | MDA 7 | 134 | 87% | 7% | 66 |
7 | MDA 7 IL 24 | 100 | 74% | 8% | 75 |
8 | MDA 7 GENE | 96 | 91% | 4% | 40 |
9 | IL 22 | 93 | 51% | 14% | 132 |
10 | APOPTOSIS INDUCING CYTOKINE | 91 | 89% | 4% | 41 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Therapeutic opportunities of the IL-22-IL-22R1 system | 2014 | 48 | 167 | 71% |
Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22 | 2011 | 259 | 109 | 46% |
IL-22, not simply a Th17 cytokine | 2013 | 72 | 165 | 41% |
Biology of interleukin-22 | 2010 | 152 | 107 | 72% |
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease | 2011 | 289 | 307 | 34% |
Interleukin-22: A likely target for treatment of autoimmune diseases | 2014 | 14 | 51 | 71% |
Recent advances in IL-22 biology | 2011 | 106 | 60 | 57% |
Emerging role of interleukin-22 in autoimmune diseases | 2013 | 23 | 63 | 67% |
Gene Therapies for Cancer: Strategies, Challenges and Successes | 2015 | 3 | 170 | 32% |
IL-10 family of cytokines | 2010 | 74 | 109 | 71% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VCU MOL MED | 12 | 31% | 3.6% | 33 |
2 | HERBERT IRVING COMPREHENS CANC UROL | 9 | 59% | 1.1% | 10 |
3 | VCU MASSEY CANC | 7 | 25% | 2.7% | 25 |
4 | INDEPENDENCE BLUE CROSS CARDIOVASC | 7 | 57% | 0.9% | 8 |
5 | INTERDISCIPLINARY GRP MOL IMMUNOPATHOL DERMATOL M | 7 | 46% | 1.2% | 11 |
6 | HERBERT IRVING COMPREHENS CANC NEUROSURG | 6 | 50% | 0.9% | 8 |
7 | INTERDISCIPLINARY GRP MOL IMMUNOPATHOL | 4 | 38% | 1.0% | 9 |
8 | HERBERT IRVING COMPREHENS CANC PATHOL | 4 | 44% | 0.8% | 7 |
9 | EXPT MED UNIT | 3 | 13% | 2.6% | 24 |
10 | UNIT 445 | 3 | 27% | 1.0% | 9 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000188527 | IFN LAMBDA//IL 29//INTERLEUKIN 29 |
2 | 0.0000150104 | IL 17//INTERLEUKIN 17//TH17 |
3 | 0.0000099817 | IL 10R1//VIRAL IL 10//INTERLEUKIN 10 RECEPTOR |
4 | 0.0000098703 | IL 33//INTERLEUKIN 33//ST2 |
5 | 0.0000084749 | PSORIASIS//TAIYUAN CITY HOSP//MOUSE TAIL TEST |
6 | 0.0000048572 | IL 9//INTERLEUKIN 9//MAGAININ MOL MED |
7 | 0.0000037725 | ONCOLYTIC VIRUS//VIROTHERAPY//ONCOLYTIC ADENOVIRUS |
8 | 0.0000037473 | RHEUMATOL CONNECT TISSUE//COMMON RECEPTOR CHAIN//HLTH SCI B115 |
9 | 0.0000036994 | IL 37//TIR8//INTERLEUKIN 37 |
10 | 0.0000032298 | GADD45//GADD45A//GREENSCREEN HC |